{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:02:18Z","timestamp":1785798138047,"version":"3.56.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02758-4","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:02:14Z","timestamp":1702382534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4985-0546","authenticated-orcid":false,"given":"Rachel E.","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-1808","authenticated-orcid":false,"given":"Jessica N.","family":"Pixley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0715-9204","authenticated-orcid":false,"given":"Christina L.","family":"Kontzias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-6289","authenticated-orcid":false,"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"2758_CR1","unstructured":"Medical Dictionary for Regulatory Activities (2023) Vision for MedDRA. https:\/\/www.meddra.org\/about-meddra\/vision. Accessed 27 Feb 2023"},{"issue":"2\u20133","key":"2758_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s1386-5056(00)00062-9","volume":"57","author":"M Yokotsuka","year":"2000","unstructured":"Yokotsuka M, Aoyama M, Kubota K (2000) The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM). Int J Med Inform 57(2\u20133):139\u2013153. https:\/\/doi.org\/10.1016\/s1386-5056(00)00062-9","journal-title":"Int J Med Inform"},{"key":"2758_CR3","unstructured":"Medical Dictionary for Regulatory Activities (2023) MedDRA hierarchy. https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy. Accessed 27 Feb 2023"},{"issue":"2","key":"2758_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109\u2013117. https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug Saf"},{"key":"2758_CR5","unstructured":"ClinicalTrials.gov (2023) ClinicalTrials.gov results data element definitions for interventional and observational studies. https:\/\/prsinfo.clinicaltrials.gov\/results_definitions.html. Accessed 27 Feb 2023"},{"issue":"3","key":"2758_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/12034754231163793","volume":"27","author":"MJ Chang","year":"2023","unstructured":"Chang MJ, Kontzias CL, Pixley JN, Feldman SR (2023) Understanding the medical dictionary for regulatory activities for assessing safety in atopic dermatitis clinical trials. J Cutan Med Surg 27(3):285\u2013286. https:\/\/doi.org\/10.1177\/12034754231163793","journal-title":"J Cutan Med Surg"},{"key":"2758_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3389\/fphar.2019.00975","volume":"10","author":"C Bousquet","year":"2019","unstructured":"Bousquet C, Souvignet J, Sadou \u00c9, Jaulent MC, Declerck G (2019) Ontological and non-ontological resources for associating medical dictionary for regulatory activities terms to SNOMED clinical terms with semantic properties. Front Pharmacol 10:975. https:\/\/doi.org\/10.3389\/fphar.2019.00975","journal-title":"Front Pharmacol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02758-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02758-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02758-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T16:06:19Z","timestamp":1704729979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02758-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02758-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Steven Feldman has received research, speaking and\/or consulting support from AbbVie, Accordant, Almirall, Alvotech, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Eurofins, Forte, Galderma, Helsinn, Janssen, Leo Pharma, Micreos, Mylan, Novartis, Ono, Ortho Dermatology, Pfizer, Regeneron, Samsung, Sanofi, Sun Pharma, UCB, Verrica, Voluntis, and vTv Therapeutics. He is founder and part owner of Causa Research and holds stock in Sensal Health. Rachel Tao, Jessica Pixley, and Christina Kontzias have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"41"}}